FDA Investigator Lisa R Whitt
Lisa R Whitt has conducted inspections on 42 sites in 2 countries as of 24 Feb 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
42
Last Inspection Date:
24 Feb 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Bolivia (Plurinational State of)
FDA Investigators that have inspected at least one site in common with Lisa R Whitt:
Abby Lmozeke Baker,
Ademola O Daramola,
Akbar J Zaidi,
Albert F Peacock, PhD,
Andrea A Branche,
Andrew B Bevill,
Anh M Lac,
Anya Dlockett Evans,
Aqualia L Nelson,
Barbara G Peoples,
Bing Lin,
Blondell W Johnson,
Bonita S Chester,
Brandi E Williams,
Brian J Ryan,
Bryce A May,
Camerson E Moore,
Carla J Lundi,
Charles D Brown,
Charles I Ann,
Christopher D Rush,
Christopher N Tran,
Chunsheng Cai, PhD,
Claire M Minden,
Clinton J Lott,
Connie L Hannon Rabel,
Crystal S Harris,
Damaris Y Hernandez,
Daniel J Lahar,
Darla J Christopher,
David M Beltran,
Decarlos A Gomez,
Denise Connelly,
Deniza Karacic,
Diane Hall,
Dr. Jason R Caballero,
Elisa M Fleming,
Elizabeth D Connell,
Ellen J Kleintop,
Ellen J Tave,
Elmina E Akwo,
Eric L Dong, BS,
Ernest Serna, III,
Frans E Mercado,
Frederic W French, III,
Gloria A Milster,
H Ljamilla Selby,
Haijing Hu,
Hala L Selby,
Hoimay Chan,
Jeffrey R Wooley,
Jeremy L Stukes,
Jessica M Simpson, PhD,
Jodi M Gatica,
Jose Acruz Gonzalez,
José E Meléndez,
Jose Martinez, Jr,
Jude C Dikes,
Karen C Daugherty,
Kari M Johansen,
Kari M Laynor,
Karlton T Watson,
Kathleen B Swat,
Kathleen Chmura Shaffer,
Kevin T Nguyen,
Khunnathee Stoner,
L Grant,
Lane V Christensen, PhD,
Latorie S Jones,
Latrecia D Stubbs,
Lauren E Skokan,
Lauren M Lilly, PhD,
Laurimer Kuilan Torres,
LCDR Ismael Olvera, IV,
Linda Linh N Adams,
Linda Thai,
Lisa M Puttonen,
Lisa R Jennings,
Liza L Quiles,
Lori M Graham,
Lorie S Hannappel,
Marcia G Evans,
Margaret M Annes,
Mark C Flotte,
Massoud Motamed,
Merelynn Rhoten,
Michael I Gorman,
Michael L Jones,
Michelle A Krayer,
Monique S Frazier,
Nimmy Mathews,
Noreen Muñiz,
Patrice S Hall,
Patrick D Stone, MS,
Patty P Kaewussdangkul,
Paula J Perry,
Pauline N Logan,
Philip M Steele, PhD,
Pitman,
Preston B Hoover,
Rebecca Co Bryan,
Richard J Bashay,
Richard T Riggie,
Robert M Tillman,
Rodney L Tinzie,
Ronda Rloyd Jones,
Rosia E Nesbitt,
Roy R Rinc,
Samuel A Hamblin,
Sandy J Ziegler,
Sara Rothman,
Scott T Ballard,
Sha'tina R Alridge,
Shanna N Purdy,
Shawn E Larson,
Shelby N Turner,
Sherrie L Krolczyk,
Sina Shojaee,
Stacie A Woods,
Stephen D Brown,
Stephen L Beekman,
Terrance L Thomas,
Terri E Gibson,
Theresa Kirkham (NMI),
Timothy B Webb,
Timothy H Vo,
Torrance J Slayton,
Tracy J Washington,
Tricia S Martinez,
Tricia Y Samaniego,
Trina K Vick,
Vitaliy N Guyvan,
Young M Yoon,
Zerita White
Lisa R Whitt's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2020 | FDA 483 | OHM PHARMA INC. - Form 483, 2020-03-18 |
| December, 2016 | FDA 483 | QuVa Pharma, Inc. - Form 483, 2016-12-08 |
| February, 2018 | FDA 483 | Monarch PCM, LLC - Form 483, 2018-02-06 |
| September, 2018 | FDA 483 | Qualgen LLC - Form 483, 2018-09-13 |
| October, 2016 | FDA 483 Response | Cantrell Drug Company - Form 483R, 2016-11-04 |
| April, 2018 | FDA 483 | BioTE Medical - Form 483, 2018-04-23 |
| October, 2017 | FDA 483 | Carrollclean, LLC - Form 483, 2017-10-20 |
| July, 2017 | FDA 483 | Neos Therapeutics, LP - Form 483, 2017-07-25 |
| October, 2016 | FDA 483 | Cantrell Drug Company - Form 483, 2016-10-14 |
| September, 2018 | FDA 483 | Qualgen, LLC - Form 483, 2018-09-13 |
| November, 2019 | FDA 483 | D&d Essential Oils, Llc. - Form 483, 2019-11-20 |
| March, 2019 | EIR | ZECO, LLC - EIR, 2019-03-15 |
| February, 2018 | EIR | Monarch PCM, LLC - EIR, 2018-02-06 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more